New combo pill shows promise for diabetes control over one year
NCT ID NCT02220907
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a once-daily combination of two diabetes drugs (Teneligliptin and Canagliflozin) in 153 Japanese adults with type 2 diabetes whose blood sugar was not well controlled on Teneligliptin alone. Participants took the combo pill for 52 weeks to see if it was safe and improved blood sugar levels. The goal was better long-term disease management, not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research site
Chugoku, Japan
-
Research site
Chūbu, Japan
-
Research site
Hokkaido, Japan
-
Research site
Kanto, Japan
-
Research site
Kyushu, Japan
-
Research site
Tōhoku, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Could a peptide injection help rebuild Insulin-Making cells?
- A pill for diabetes? new oral drug aims to rival injections